TechCrunch

DECEMBER 15, 2022

That’s why we weren’t very surprised when a slew of investors told us they rarely see a biotech startup that doesn’t incorporate AI in some form or other these days. But despite becoming quite the buzzword, AI’s apparent ubiquity in biotech isn’t actually driving deal flow or higher valuations.

Biotech 242

Biotech Technical Review Development Team Review Systems Review 242

TechCrunch

MARCH 21, 2023

When you think of life sciences and biotech hubs in the U.S., Portal Innovations , a biotech VC firm based in Chicago, is trying to broaden everyone’s horizons and give opportunities to biotech startups growing out of labs in Chicago, Atlanta, and hopefully beyond. where do you travel to in your mind? The Bay Area?

Biotech 203

Biotech Development Team Review Technical Review Innovation 203

Perficient

JANUARY 16, 2024

For more than 25 years, we’ve grown our presence, our talent, our skills, and our global footprint so that we can continually provide critical Agile software development and delivery services to the world’s biggest brands. Today, we’re thrilled to welcome nearly 175 new colleagues to the Perficient team. Why SMEDIX, and why now?

Software Development 64

Software Development Development Team Review Software Review Technical Review 64

TechCrunch

APRIL 30, 2021

Which is just one snapshot, but a relevant one given how hard it can be to produce accurate early-stage startup market analysis at this scale. Mix in the impending SPAC-led debut of eToro, general bullishness in the cryptocurrency space, record highs for some equities markets, and recent rounds from Public.com, M1 Finance and U.K.-based

Fintech 195

Fintech Technical Review Windows Biotech 195